
N-BENZYL-2-PHENYLETHYLAMINE
CAS No. 3647-71-0
N-BENZYL-2-PHENYLETHYLAMINE( —— )
Catalog No. M22262 CAS No. 3647-71-0
N-BENZYL-2-PHENYLETHYLAMINE is an inhibitor of rel+ Escherichia coli B Phe-tRNA.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 177 | In Stock |
![]() ![]() |
5MG | 268 | In Stock |
![]() ![]() |
10MG | 408 | In Stock |
![]() ![]() |
25MG | 672 | In Stock |
![]() ![]() |
50MG | 945 | In Stock |
![]() ![]() |
100MG | 1278 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameN-BENZYL-2-PHENYLETHYLAMINE
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-BENZYL-2-PHENYLETHYLAMINE is an inhibitor of rel+ Escherichia coli B Phe-tRNA.
-
DescriptionN-BENZYL-2-PHENYLETHYLAMINE is an inhibitor of rel+ Escherichia coli B Phe-tRNA.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorrel+ Escherichia coli B Phe-tRNA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3647-71-0
-
Formula Weight211.3
-
Molecular FormulaC15H17N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(Cc1ccccc1)NCc2ccccc2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.R T Anderson Jr, D V Santi.Phenylalanyl transfer ribonucleic acid synthetase from Escherichia coli B. Potent inhibition by analogues of N-benzyl-2-phenylethylamine.J Med Chem. 1976 Nov;19(11):1270-5.
molnova catalog



related products
-
Physalin O
Physalin O possesses anti-inflammatory activity, it exhibited conjugating abilities with GSH and also showed significant nitric oxide (NO) production inhibiting activities.
-
Clozic
Clozic exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
-
BC-DXI-843
BC-DXI-843 is inhibitor of AIMP2-DX2, and is potential for development of novel therapeutics targeting AIMP2-DX2 in lung cancer.